Form 4: Orchestra BioMed Holdings Director, David Pacitti, Acquires Shares and Stock Options

Director David Pacitti acquired 5,376 shares of common stock and 17,068 stock options in Orchestra BioMed Holdings on June 20, 2024.

Summary

• On June 20, 2024, David Pacitti, a director of Orchestra BioMed Holdings, Inc., acquired 5,376 shares of common stock at $0.00 per share.
• These shares were awarded as restricted stock units (RSUs) that vest on June 20, 2025.
• Each RSU represents a contingent right to receive one share of common stock.
• Pacitti also acquired 17,068 stock options with an exercise price of $7.44, exercisable from June 20, 2025, and expiring on June 20, 2034.
• Following these transactions, Pacitti directly owns 17,546 shares of common stock and 17,068 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects standard insider trading activity, which can be seen as a positive sign of confidence but doesn't provide enough information to strongly influence sentiment.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director could positively influence shareholder sentiment.

Key Dates